Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Energy Sector · Guggenheim

RYVAX Expense Ratio & Fees

Ticker RYVAX · · Holdings as of Jun 30, 2026

Expense ratio
1.62%$162/yr per $10k
5-yr return
+10.3%annualized
1-yr return
+2.1%as of Dec 2025
Net assets
$41.4Mall share classes
Holdings
32

Bottom line

What is RYVAX's expense ratio?

RYVAX's expense ratio is 1.62%, or about $162 a year on every $10,000 invested. That is more expensive than 73% of energy sector funds we track (median 1.17%). Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Jul 29, 2026

RYVAX fee table

Net expense ratio1.62%
Gross expense ratio1.67%
Management fee0.85%
12b-1 (distribution) fee0.25%
Other expenses0.57%
Fee waiver / reimbursement-0.05%

Source: Fund prospectus fee table, filed Jul 29, 2026

What RYVAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
RYVAX$165$522$903$1,972

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.62% expense ratio costs roughly $85,000 in lost growth, versus about $63,800 for the median energy sector fund (1.17%).

Cheapest way to own Energy Services Fund

All share classes
TickerClassExpense ratioFront load
RYVIXInvestor Class1.37%—
RYVAXClass H1.62%—
RYESXClass A1.63%4.75%
RYVCXClass C2.38%0%